twitter logo youtube logo

Management of lung cancer


There are approximately 4,800 new cases of lung cancer and 4,000 related deaths each year in Scotland.  Eighty nine per cent of cases occur in patients over 60 years, with about 90% of patients being smokers or ex-smokers.

Remit and target users

The guideline covers all aspects of the management of patients with small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), reflecting the most recent evidence on diagnostic and staging investigations, surgery, radiotherapy and systemic anticancer therapy. It also provides information for discussion with patients and carers.

The guideline is intended for use by chest physicians, surgeons, radiologists, pathologists, medical and clinical oncologists, pharmacists, public health practitioners, nurses, general

practitioners, palliative care teams and allied health professionals.

How this guideline was developed

This guideline was developed using a standard methodology based on a systematic review of the evidence. Further details can be found in SIGN 50: A Guideline Developer’s Handbook.

Keeping up to date

This guideline was issued in 2014 and will be considered for review in three years. The review history, and any updates to the guideline in the interim period, will be noted in the review report.

If you are aware of any new evidence that would update this guideline please complete a change request form and return to:

Current < 3 years


Full guideline (PDF)

Quick reference guide (PDF)

Apple app

Android app

Supporting material

Declarations of interest (PDF)

Search narrative (PDF)

Review report (PDF)

Copyright permission (PDF)

Contact us

SIGN 137, February 2014
ISBN 978 1 905813 18 4

guidelines international network logo


HIS Healthcare Improvement Scotland logo